Dr. Cassandra Taylor, Quality Considerations for Cannabis and Cannabis-Derived Products for Use in Clinical Trials

May 2022

Cassandra Taylor, Ph.D. is a Chemist at U.S. Food and Drug Administration within the Center for Drug Evaluation and Research (CDER) and is a member of the Botanical Review Team (BRT) residing within the Office of Pharmaceutical Quality (OPQ) and serves as an expert resource on all botanical issues. Dr. Taylor received her B.S. in Chemistry from St. Francis University (2005), and her Ph.D. in Analytical Chemistry from the University of Maryland (2014). Dr. Taylor has evaluated over 100 botanical drug submissions across CDER’s clinical divisions, with a focus on cannabis submissions. She serves as a cannabis subject matter expert (SME) for CDER and across FDA, concentrating on the botanical and quality aspects of cannabis. Dr. Taylor is technical lead on the draft FDA guidance for industry titled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research.” She leads and coordinates the CDER Cannabis working group and leads many cannabis initiatives within CDER and FDA. Dr. Taylor is an active SME in the FDA cross-agency cannabis working group, Cannabis Products Committee (CPC). She collaborates with colleagues across FDA to help close substantial knowledge gaps about the science, safety, and quality of cannabis and cannabis-derived products.

Previous Webinars

Allyn C. Howlett, Ph.D

How the CB1 cannabinoid receptor communicates within the cell via associated proteins

April 11, 2024, 1 PM MST

Dr. Allyn C. Howlett is a Professor of Physiology and Pharmacology at Wake Forest University School of Medicine, Assistant Dean of WFU Graduate School Biomedical Programs, and Director of the Office of Postdoctoral Education. Dr. Howlett is an […]

Read More »

Youbin Zheng, Ph.D

How to Use Light in Cannabis Cultivation

April 17, 2024 11 AM MST

Dr. Youbin Zheng is a professor at the University of Guelph, Canada. He has more than 25 years of research experience in controlled environment plant production, and his research has resulted in more than 150 peer-reviewed scientific papers, more than ten book chapters […]

Read More »

Zamir K. Punja, Ph.D

Total yeast and mold in cannabis : How and why ?

March 20, 2024 11 AM MST

Dr. Punja completed his MSc and PhD degrees in plant pathology from
the University of California, Davis. He joined Campbell Soup Company
and was Manager of plant biotechnology until 1989, when he left to
join Simon Fraser University. Zamir’s research investigates the […]

Read More »

Ryan McLaughlin, Ph.D

From Seed to Synapse: Modeling the Long-Term
Impacts of Developmental Cannabis Exposure

March 14, 2024, 1 PM MST

Dr. Ryan McLaughlin is an Associate Professor in the Department of Integrative Physiology and Neuroscience at Washington State University (WSU). The overarching goal of Dr. McLaughlin’s research program is to determine how endogenous and exogenous cannabinoids affect the brain […]

Read More »